IFR:騰訊投資的檸萌影視傳媒計劃在香港進行3億美元IPO
IFR援引知情人士報道,騰訊控股支持的檸萌影視傳媒計劃通過香港IPO籌資約3億美元。檸檬影視已於9月29日提交了上市申請,騰訊持有該公司19.8%的股份,中金公司和摩根士丹利爲保薦人。
檸檬影視是一家基於深厚的版權IP儲備,專注創作精品劇集的中國頂級內容製作公司。自2014年於上海成立以來,致力於進行劇集的投資、製作、宣傳、營銷、衍生授權等全產業鏈運營。根據弗若斯特沙利文的資料,按2020年的收入計,在所有中國劇集公司中排名第四。
檸檬影視創作了一個非常受歡迎的關注中國家庭及教育話題的現實生活主題劇集系列,包括2016年的《小別離》、2019年的《小歡喜》及2021年的《小捨得》。亦創作了女性成長題材劇集系列,包括2020年的《二十不惑》和《三十而已》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.